BIMZELX® Approved by the U.S. FDA for the Treatment of Adults with Moderate-to-Severe Plaque Psoriasis

Media coverage

• Title	BIMZELX® Approved by the U.S. FDA for the Treatment of Adults with Moderate-to-Severe Plaque Psoriasis
  Media name/outlet	BioSpace
  Country/Territory	United States
  Date	18/10/23
  URL	ct.moreover.com/?a=52097715798&p=1gw&v=1&x=nm-JCPbh5vVQ1WiuX-Z0wA
  Persons	Mark Lebwohl

• Title	UCB: BIMZELX Approved by the U.S. FDA for the Treatment of Adults with Moderate to Severe Plaque Psoriasis
  Media name/outlet	India Pharma News
  Country/Territory	India
  Date	18/10/23
  Persons	Mark Lebwohl